Firm News

New Filing Deadline in Xarelto Cases

Publish Date : 04/05/2016

On March 21st, a federal judge in Louisiana instituted a new filing deadline in Xarelto cases. This deadline, imposed by Judge Eldon Fallon in Pretrial Order No. 11E, bars plaintiffs from filing short form complaints after May 20, 2016. Short form complaints allow plaintiffs to more quickly and easily file a lawsuit, so plaintiffs who have been harmed by Xarelto should move quickly in addressing their legal issues.

Xarelto is a prescription blood-thinning drug manufactured by Bayer and Johnson & Johnson via Janseen Pharmaceuticals, Inc. The drug received initial FDA approval in 2011 for knee and hip replacement patients. It was quickly approved to help prevent strokes in individuals with abnormal heart rhythms. Unfortunately, Xarelto was soon linked to a number of dangerous side effects, most notably uncontrollable internal bleeding.

There is no Xarelto class action lawsuit at this time. However, Xarelto cases, like most large-scale defective drug cases, is part of a Multi-District Litigation (MDL). MDLs streamline litigation and reduce costs to injury victims. Each case in the MDL is handled individually, but all cases are before the same court and subject to the same rules and court orders. Therefore, it is possible for each case in an MDL to settle for different amounts of money.  All Xarelto lawsuits were transferred to the Eastern District of Louisiana in December, 2014, as MDL 2592.

Because of Judge Fallon’s order setting a deadline for the use of short-form complaints, those who have been harmed by their use of Xarelto should act quickly to protect their legal rights. The attorney’s at McSweeney/Langevin can help you navigate the complex world of pharmaceutical litigation to get you and your family the peace-of-mind you deserve. Give us a call.

1-800-888-4425

Free Confidential Case Evaluation

To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing FREE

1-800-888-4425
FREE Case Review

An asterisk (*) indicates a required field.

[contact-form-7 id="96" title="Contact Us"]